InvestorsHub Logo
icon url

north40000

04/30/20 10:30 AM

#270400 RE: MateoPaisa #270399

How about 6-9 months before approval in European nations; did you miss that?
icon url

bidmark

04/30/20 10:33 AM

#270401 RE: MateoPaisa #270399

How much do we know about their marketing plan for the US or anywhere?
icon url

ilovetech

04/30/20 10:49 AM

#270407 RE: MateoPaisa #270399

Mateo, I respectfully disagree. What are you missing? The most important of all considerations:

-How would you compare selling an OTC like drug to a brand new Oncology drug? The difference is too enormous to attempt to make such a comparison.

-JT said, Vascepa is a highly differentiated drug in the CVD space with no competition expected for a long time to come.

-EU patents expire in 2033.

-CVD death is the number one cause of death in EU and World for that matter.

Given all the above, the notion that the train is leaving the station is absurd.

ILT
icon url

L0tsaluck2000

04/30/20 11:56 AM

#270420 RE: MateoPaisa #270399

"It is beyond obscene to me that we have absolutely no marketing/distribution plan in Europe."

How in the world would you know. Did you expect them to release a Europe marketing Plan document for you?
icon url

Jasbg

04/30/20 12:40 PM

#270427 RE: MateoPaisa #270399

Amarin 'Expect' EU approval end 2020.

As they 'Expected' to win Patent case.

As they 'didn't anticipate Corona Crisis.
----------------------------------------

The world of 2021 will almost certainly 'be different' to what we might think today - so I totally agree - with the cautious approach to future by Amarin - moneywise.
----------------------------------------

One thing that has been debated a lot (also lately) is the possible settlement with Hikma/Reddy.

I did not hear JT refer to it in anyway - and no questions about it either.
-----------------------------

What do experienced people here think about that. Does this mean that 'Settlement' is completely of the table ?

Jasbg
icon url

concapk

04/30/20 6:06 PM

#270556 RE: MateoPaisa #270399

get your obscene right...

let's see

1. AMARIN APPROVAL from FDA Dec. 19,2019
2. AMARIN submits to EU in Jan. 2020
3. AMARIN receives 120 day letter from EU in late March 2020.
4. Amarin responds to EU early MAY 2020
5. AMARIN will receive response from EU July/ AUGUST 2020
6. AMARIN may have to respond to minor inquiry again from EU, or could be clear to go.
7. AMARIN could get approval from EU Sept/Oct, 2020

So what are you complaining about or do you just like to complain????
icon url

concapk

05/01/20 6:17 PM

#270818 RE: MateoPaisa #270399

Mateo

Yes you are stupid.. plain as day

We have to get approval first to market in the EU, which will be 3rd/4th quarter 2020.... per the CC, JT is talking to many parties whether to GIA/PARTNER... He is already making plans either way....

READ this text again .... your head must be in the clouds or buried in the ground...